Milk Proteins, Ambulatory Blood Pressure and Vascular Function
NCT ID: NCT02090842
Last Updated: 2016-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
38 participants
INTERVENTIONAL
2014-02-28
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This research includes both an acute and chronic intervention study which have been independently powered on the appropriate outcome measures. This has generated different sample size requirements for the two studies (Actual participants on the acute study: n=27, and on the chronic study: n=38).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Whey Protein on Blood Pressure
NCT00659672
Acute Whey Protein And Casein Supplementation: Effect On Protein Metabolism After Resistance Exercise
NCT04648384
Clinical Trial of Dietary Protein and Blood Pressure
NCT00046566
The Effects of Milk Proteins on Blood Pressure
NCT00471263
Anabolic Effects of Whey and Casein After Strength Training in Young and Elderly
NCT02968888
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Whey protein isolate
Subjects are asked to supplement their habitual diet with 56 g of whey protein isolate a day for 8 weeks.
Whey protein isolate
Ca-caseinate
Subjects are asked to supplement their habitual diet with 56 g of Ca-caseinate a day for 8 weeks.
Ca-caseinate
Maltodextrin
Subjects are asked to supplement their habitual diet with 54 g of maltodextrin a day for 8 weeks.
Maltodextrin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ca-caseinate
Maltodextrin
Whey protein isolate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Blood pressure: 120/80-159/99
* Age: 30-77 years
* BMI 20-40 kg/m2
* Glucose \<7 mmol/l (Not diagnosed with diabetes)
* Chol \<8 mmol/l
* TAG \<4 mmol/l
* Normal liver and kidney function
* Haemoglobin (\>110 g/dl women; 140g/dl men)
Exclusion Criteria
* Coeliac disease
* Renal, gastrointestinal, respiratory, endocrine, liver disease or cancer
* Surgery in the previous 6 months
* Secondary hypertension
* Excess alcohol consumption (drinking \>28 unit/wk man; \>21 unit/wk women)
* Smoker
* Vegan
* Taking nutritional supplementation (e.g. fish oil, proteins)
* Anaemia
30 Years
77 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Volac Int. Ltd.
UNKNOWN
University of Reading
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julie Lovegrove
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julie A. Lovegrove, BSc, PhD, RNutr
Role: PRINCIPAL_INVESTIGATOR
University of Reading
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Food and Nutritional Sciences, University of Reading
Reading, Berks, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pal S, Ellis V. Acute effects of whey protein isolate on blood pressure, vascular function and inflammatory markers in overweight postmenopausal women. Br J Nutr. 2011 May;105(10):1512-9. doi: 10.1017/S0007114510005313. Epub 2011 Jan 28.
Pal S, Ellis V. The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals. Obesity (Silver Spring). 2010 Jul;18(7):1354-9. doi: 10.1038/oby.2009.397. Epub 2009 Nov 5.
Fekete AA, Giromini C, Chatzidiakou Y, Givens DI, Lovegrove JA. Whey protein lowers blood pressure and improves endothelial function and lipid biomarkers in adults with prehypertension and mild hypertension: results from the chronic Whey2Go randomized controlled trial. Am J Clin Nutr. 2016 Dec;104(6):1534-1544. doi: 10.3945/ajcn.116.137919. Epub 2016 Oct 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12/40
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.